Records containing: Influenza

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2013-09-02
  The Cost of Illness Associated With Influenza in the UK
• CLINICAL_TRIALS study record update · 2013-08-30
  Open, Non-randomized Trial to Assess the Immunogenicity and Safety of the 2013/2014-season Virosomal Subunit Influenza Vaccine in Elderly and Young Subjects According to EMA Regulations
• CLINICAL_TRIALS study record update · 2013-08-23
  A Randomized, Double-Blinded, Placebo-Controlled Phase I/II, Dose-Ranging Study of the Safety, Reactogenicity, and Immunogenicity of Intramuscular Inactivated Influenza A/H5N1 Vaccine in Healthy Elderly Adults
• CLINICAL_TRIALS study record update · 2013-08-23
  In Depth Immunologic Studies in Healthy Young Adults Who Receive The Standard Dose Fluzone® (15mcgHA/Virus Strain) Trivalent Inactivated Influenza Virus Vaccine
• CLINICAL_TRIALS study record update · 2013-08-23
  A Randomized, Double-Blinded, Placebo-Controlled, Phase I/II, Dose-Ranging Study of the Safety, Reactogenicity, and Immunogenicity of Intramuscular Inactivated Influenza A/H5N1 Vaccine in Healthy Adults
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2013-08-23
  A Randomized, Double-Blinded, Placebo-Controlled, Phase I/II, Dose-Ranging Study of the Safety, Reactogenicity, and Immunogenicity of Intramuscular Inactivated Influenza A/H7N7 Vaccine in Healthy Adults
• CLINICAL_TRIALS study record update · 2013-08-23
  Inpatient Surveillance for Influenza Infections in Adults
• CLINICAL_TRIALS study record update · 2013-08-16
  Pilot Study of the Genotypic Analysis of Patients Infected With Influenza Virus Compared With Uninfected Spouse/Close Contact Controls
• CLINICAL_TRIALS study record update · 2013-08-16
  Evaluation of a Booster Dose of A/Vietnam/1203/04 (H5N1) Vaccine Administered at 6 Months to Healthy Adult Subjects After a Two Dose Schedule at 0 and 1 Months
• CLINICAL_TRIALS study record update · 2013-08-16
  Cell-Mediated Immune Responses to Influenza A/H5N1 Vaccine
• CLINICAL_TRIALS study record update · 2013-08-16
  T and B Cell Immune Responses to Influenza A/H5N1 Vaccine
• CLINICAL_TRIALS study record update · 2013-08-09
  Comparison of Time From Symptom Onset to Oseltamivir Access When Oseltamivir is Prescribed by Pharmacists vs. Physicians and the Impact on Symptoms, Oseltamivir Resistance, and Patient Safety
• CLINICAL_TRIALS study record update · 2013-08-05
  Impact of Immunization Routes on the Immune Response to Influenza Vaccine
• CLINICAL_TRIALS study record update · 2013-07-29
  Double-blind, Randomized, Placebo-controlled Clinical Study Investigating Efficacy and Safety of Arbidol (Umifenovir) in Treatment and Prophylaxis of Influenza and Common Cold.
• CLINICAL_TRIALS study record update · 2013-07-29
  SEA022 Oseltamivir Treatment in Children Under One Year of Age With Moderate or Severe Influenza Lower Respiratory Tract Infection - a Clinical and Pharmacokinetic Study.
• CLINICAL_TRIALS study record update · 2013-07-24
  A Post-marketing Study to Monitor the Safety of Beijing Tiantan Biological's Influenza Virus Vaccine Administered in Chinese Subjects Aged 60 Years or Older
• CLINICAL_TRIALS study record update · 2013-07-23
  Evaluation of In Vitro Cross-Reactivity With Avian Influenza H5N1 Virus in Healthy Volunteers Vaccinated With a Prime Boost Regimen of Seasonal Influenza Vaccine
• CLINICAL_TRIALS study record update · 2013-07-19
  A Phase I C Clinical Study With Influenza Antiviral DAS181-F03: Double-Blind, Randomized, Placebo-Controlled, Single Dose and Multiple Dose Escalation Study in Healthy Adults
• CLINICAL_TRIALS study record update · 2013-07-18
  A Phase 2 Randomized, Observer-Blind, Dose-Ranging Study to Evaluate the Immunogenicity and Safety of Quadrivalent Seasonal Virus-Like Particle (VLP) Influenza Vaccine (Recombinant) in Healthy Young (18-64) Adults
• CLINICAL_TRIALS study record update · 2013-07-18
  A Phase 2a Randomized, Double-Blind, Active-Controlled Trial to Evaluate the Safety and Immunogenicity of a Trivalent Seasonal Influenza Virus-Like Particle (VLP) Vaccine (Recombinant) in Older Adults
• CLINICAL_TRIALS study record update · 2013-07-18
  A Phase 2a Randomized, Double Blind, Placebo Controlled Trial to Evaluate the Safety and Immunogenicity of a Seasonal Influenza Virus-Like Particle (VLP) Vaccine (Recombinant) in Healthy Adults
• CLINICAL_TRIALS study record update · 2013-07-09
  Clinical Study in Children, 6 Months to 3 Years of Age, to Assess the Immunogenicity and Safety of Two Dose Levels of Thimerosal-free Fluviral® Vaccine, Using a Licensed Influenza Virus Vaccine, Vaxigrip® as the Control
• CLINICAL_TRIALS study record update · 2013-06-24
  Demonstrate the Lot-to-lot Consistency of 3 Consecutive Production Lots of an Adjuvanted Influenza Vaccine Candidate and Evaluate the Safety of an Adjuvanted Influenza Vaccine Candidate Versus Fluarix™ Administered Intramuscularly in Elderly
• CLINICAL_TRIALS study record update · 2013-06-17
  Partially-blind Immunogenicity and Safety Study of GSK Biologicals' Seasonal Influenza Vaccine GSK2321138A in Adults.
• CLINICAL_TRIALS study record update · 2013-06-11
  A Double-Blind, Placebo-Controlled, Single Ascending Dose Study of the Safety, Tolerability, and Pharmacokinetics of AVI-7100 in Healthy Subjects